Clinical Trials for Extensive Stage Small Cell Lung Cancer

Find clinical trials for extensive stage small cell lung cancer. Discover research opportunities and treatment options in your area.

12 Active Trials Found

Showing 12 trials on this page

Page 1 of 1

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

NCT ID: NCT05142696

This clinical trial is studying a new treatment approach for patients with extensive stage small cell lung cancer (ES-SCLC), which is a type of aggressive lung cancer. The researchers want to find ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Lexington, Kentucky, United States, Cleveland, Ohio, United States +36 more

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

NCT ID: NCT07107490

This clinical trial is testing a new drug called ALPS12 in people with extensive-stage small cell lung cancer, which means the cancer has spread widely in the body. The main goal of this early-phas...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Kashiwa, Chiba, Japan

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

NCT ID: NCT06598306

This clinical trial, called DeLLphi-308, is studying a new treatment called tarlatamab for patients with extensive stage small cell lung cancer (ES-SCLC). The main goal of the study is to understan...

Recruiting

Phase: PHASE1 Type: interventional Locations: Sioux Falls, South Dakota, United States, Seattle, Washington, United States +30 more

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

NCT ID: NCT07037758

This clinical trial is studying a new combination of two medicines, tarlatamab and AB248, to see if they are safe and well-tolerated in people with extensive stage small cell lung cancer (ES-SCLC) ...

Not yet recruiting

Phase: PHASE1 Type: interventional

Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer

NCT ID: NCT04699838

This clinical trial is studying a new treatment approach for patients with extensive stage small cell lung cancer, which is a type of lung cancer that has spread beyond the lungs. The trial will fi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States, Iowa City, Iowa, United States +3 more

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

NCT ID: NCT05468489

This clinical trial is studying the combination of a new treatment called Serplulimab with standard chemotherapy (Carboplatin and Etoposide) for patients with extensive stage small cell lung cancer...

Recruiting

Phase: PHASE3 Type: interventional Locations: Lebanon, New Hampshire, United States, Canton, Ohio, United States +141 more

MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer

NCT ID: NCT05903092

This clinical trial is studying a new treatment combination for patients with extensive stage small cell lung cancer (SCLC), a type of lung cancer that has spread widely in the body. The treatment ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Iowa City, Iowa, United States, Charlottesville, Virginia, United States +3 more

Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

NCT ID: NCT06897579

This clinical trial is exploring new treatment options for patients with extensive stage small cell lung cancer (ES-SCLC). Researchers want to see how effective and safe a combination of two differ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shenyang, Liaoning, China, Beijing, , China +26 more

Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC

NCT ID: NCT06597513

This clinical trial is investigating a new treatment approach for adults with extensive-stage small cell lung cancer (ES-SCLC), which is a type of lung cancer that has spread widely in the body. Th...

Not yet recruiting

Phase: PHASE1 Type: interventional

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

NCT ID: NCT06323265

This clinical trial is studying the combination of a medication called Adebrelimab with chemotherapy and possibly chest radiation therapy for patients with extensive stage small cell lung cancer. T...

Recruiting

Type: observational Locations: Shijiazhuang, Hebei, China

A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer

NCT ID: NCT06016270

This clinical trial is investigating a new treatment approach for patients with extensive stage small cell lung cancer (SCLC) that has returned or did not respond to previous treatments. The study ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Seoul, , Korea, Republic Of +9 more

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

NCT ID: NCT05896059

This clinical trial is studying a new treatment combination for patients with extensive stage small cell lung cancer (ES-SCLC) who have not received any prior treatment. The trial is looking at whe...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions